D.E. Shaw & Co’s ICU Medical ICUI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-6,605
| Closed | -$942K | – | 4762 |
|
|
2025
Q4 | $942K | Buy |
+6,605
| New | +$885K | ﹤0.01% | 3586 |
|
|
2025
Q3 | – | Sell |
-56,360
| Closed | -$7.45M | – | 4726 |
|
|
2025
Q2 | $7.45M | Sell |
56,360
-8,259
| -13% | -$1.12M | 0.01% | 1726 |
|
|
2025
Q1 | $8.97M | Buy |
+64,619
| New | +$10M | 0.01% | 1478 |
|
|
2024
Q2 | – | Sell |
-80,892
| Closed | -$8.68M | – | 4634 |
|
|
2024
Q1 | $8.68M | Buy |
80,892
+68,706
| +564% | +$6.83M | 0.01% | 1467 |
|
|
2023
Q4 | $1.22M | Buy |
+12,186
| New | +$1.19M | ﹤0.01% | 3012 |
|
|
2023
Q2 | – | Sell |
-1,444
| Closed | -$238K | – | 4371 |
|
|
2023
Q1 | $238K | Hold |
1,444
| – | – | ﹤0.01% | 3838 |
|
|
2022
Q4 | $227K | Hold |
1,444
| – | – | ﹤0.01% | 4197 |
|
|
2022
Q3 | $217K | Sell |
1,444
-7,074
| -83% | -$1.18M | ﹤0.01% | 4445 |
|
|
2022
Q2 | $1.4M | Sell |
8,518
-22,066
| -72% | -$4.25M | ﹤0.01% | 3383 |
|
|
2022
Q1 | $6.81M | Buy |
30,584
+6,516
| +27% | +$1.46M | 0.01% | 1980 |
|
|
2021
Q4 | $5.71M | Sell |
24,068
-14,341
| -37% | -$3.35M | ﹤0.01% | 2230 |
|
|
2021
Q3 | $8.96M | Buy |
38,409
+8,772
| +30% | +$1.84M | 0.01% | 1598 |
|
|
2021
Q2 | $6.1M | Sell |
29,637
-4,597
| -13% | -$946K | 0.01% | 1884 |
|
|
2021
Q1 | $7.03M | Buy |
34,234
+10,563
| +45% | +$2.23M | 0.01% | 1610 |
|
|
2020
Q4 | $5.08M | Sell |
23,671
-19,515
| -45% | -$3.79M | ﹤0.01% | 1856 |
|
|
2020
Q3 | $7.89M | Buy |
43,186
+2,240
| +5% | +$422K | 0.01% | 1395 |
|
|
2020
Q2 | $7.55M | Buy |
40,946
+15,236
| +59% | +$3.03M | 0.01% | 1368 |
|
|
2020
Q1 | $5.19M | Sell |
25,710
-8,505
| -25% | -$1.64M | 0.01% | 1437 |
|
|
2019
Q4 | $6.4M | Sell |
34,215
-46,829
| -58% | -$8.06M | 0.01% | 1541 |
|
|
2019
Q3 | $12.9M | Buy |
81,044
+70,894
| +698% | +$14.1M | 0.02% | 1008 |
|
|
2019
Q2 | $2.56M | Buy |
10,150
+5,516
| +119% | +$1.28M | ﹤0.01% | 2063 |
|
|
2019
Q1 | $1.11M | Sell |
4,634
-2,619
| -36% | -$628K | ﹤0.01% | 2548 |
|
|
2018
Q4 | $1.67M | Buy |
7,253
+483
| +7% | +$119K | ﹤0.01% | 2301 |
|
|
2018
Q3 | $1.91M | Sell |
6,770
-32,561
| -83% | -$9.54M | ﹤0.01% | 2227 |
|
|
2018
Q2 | $11.6M | Buy |
39,331
+38,208
| +3,402% | +$10.4M | 0.02% | 1000 |
|
|
2018
Q1 | $283K | Sell |
1,123
-284
| -20% | -$66.7K | ﹤0.01% | 3177 |
|
|
2017
Q4 | $304K | Buy |
1,407
+200
| +17% | +$40.5K | ﹤0.01% | 3238 |
|
|
2017
Q3 | $224K | Sell |
1,207
-1,833
| -60% | -$320K | ﹤0.01% | 3258 |
|
|
2017
Q2 | $524K | Sell |
3,040
-900
| -23% | -$144K | ﹤0.01% | 2793 |
|
|
2017
Q1 | $602K | Sell |
3,940
-2,082
| -35% | -$304K | ﹤0.01% | 2630 |
|
|
2016
Q4 | $887K | Sell |
6,022
-13,025
| -68% | -$1.89M | ﹤0.01% | 2532 |
|
|
2016
Q3 | $2.41M | Buy |
19,047
+390
| +2% | +$47K | ﹤0.01% | 1786 |
|
|
2016
Q2 | $2.1M | Buy |
18,657
+5,803
| +45% | +$602K | ﹤0.01% | 1900 |
|
|
2016
Q1 | $1.34M | Sell |
12,854
-10,790
| -46% | -$1.03M | ﹤0.01% | 2165 |
|
|
2015
Q4 | $2.67M | Sell |
23,644
-77,680
| -77% | -$8.58M | ﹤0.01% | 1903 |
|
|
2015
Q3 | $11.1M | Sell |
101,324
-11,050
| -10% | -$1.18M | 0.02% | 903 |
|
|
2015
Q2 | $10.8M | Sell |
112,374
-2,826
| -2% | -$264K | 0.02% | 985 |
|
|
2015
Q1 | $10.7M | Buy |
115,200
+375
| +0.3% | +$32.8K | 0.02% | 924 |
|
|
2014
Q4 | $9.4M | Buy |
114,825
+81,906
| +249% | +$6.28M | 0.01% | 1152 |
|
|
2014
Q3 | $2.11M | Sell |
32,919
-28,807
| -47% | -$1.76M | ﹤0.01% | 2197 |
|
|
2014
Q2 | $3.75M | Buy |
61,726
+19,531
| +46% | +$1.15M | 0.01% | 1821 |
|
|
2014
Q1 | $2.53M | Buy |
+42,195
| New | +$2.6M | ﹤0.01% | 2157 |
|
|
2013
Q3 | – | Sell |
-11,072
| Closed | -$798K | – | 4365 |
|
|
2013
Q2 | $798K | Buy |
+11,072
| New | +$732K | ﹤0.01% | 2895 |
|
Other funds holding ICUI
VPM
VCM
RRAM
D.E. Shaw & Co's ICUI Position: Q1 2026 in Review
D.E. Shaw & Co sold out of ICU Medical (ICUI) in Q1 2026, closing a stake of 6,605 shares — an estimated $942K sold.
D.E. Shaw & Co first reported a position in ICUI in Q2 2013 and held it in 43 quarters. The position peaked at $12.9M in Q3 2019. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.
- D.E. Shaw & Co reported no remaining ICU Medical position as of Q1 2026 after selling out during the quarter.
- D.E. Shaw & Co sold 6,605 ICU Medical shares in Q1 2026, an estimated $942K.
- D.E. Shaw & Co first reported a position in ICU Medical in Q2 2013 and held it in 43 quarters.
- D.E. Shaw & Co's ICU Medical position peaked at $12.9M in Q3 2019.
- 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.